Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bartolome Celli

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
American Journal of Respiratory and Critical Care Medicine|May 11, 2023
From Laënnec's Stethoscope to the Magic of Imaging, Big Data and Artificial Intelligence: A Timeline of Precision Medicine for Patients with Chronic Obstructive Pulmonary DiseaseBartolome Celli
Archivos De Bronconeumologia|April 11, 2017
Is the Blood Eosinophil Count a Useful Biomarker in COPD? The devil is in the Details!Bartolome Celli
Chest|March 9, 2023
Screening for COPD: Challenging the United Sates Preventive Services Task Force RecommendationBartolome Celli
Chest|January 21, 2006
COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: time to look beyond the FEV1Bartolome Celli
American Journal of Respiratory and Critical Care Medicine|July 18, 2025
Reply to Bardsley <i>et al.</i>: Current Smoking and Pharmacological Treatment Responses in COPD: Not Clear-CutBartolome Celli
American Journal of Respiratory and Critical Care Medicine|September 29, 2022
Reply to Harber and to Confalonieri <i>et al.</i>Bartolome Celli, Leonardo Fabbri
American Journal of Respiratory and Critical Care Medicine|November 1, 2014
Chronic obstructive pulmonary disease: different risk factors and different natural histories?Jørgen Vestbo, Bartolome Celli
The European Respiratory Journal|December 14, 2023
Reply: Simplifying pharmacotherapy for patients with COPD: a viewpointBartolome Celli, Jørgen Vestbo
Respiration; International Review of Thoracic Diseases|January 17, 2021
Triple Therapy Is Also Effective in Real-World When Used in Chronic Obstructive Pulmonary Disease Patients Who Are Frequent ExacerbatorsMario Cazzola, Bartolome Celli
Archivos De Bronconeumologia|December 4, 2022
Challenges in the Pharmacotherapy of COPD SubtypesFrancesca Polverino, Bartolome Celli
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
American Journal of Respiratory and Critical Care Medicine|May 11, 2023
From Laënnec's Stethoscope to the Magic of Imaging, Big Data and Artificial Intelligence: A Timeline of Precision Medicine for Patients with Chronic Obstructive Pulmonary DiseaseBartolome Celli
Archivos De Bronconeumologia|April 11, 2017
Is the Blood Eosinophil Count a Useful Biomarker in COPD? The devil is in the Details!Bartolome Celli
Chest|March 9, 2023
Screening for COPD: Challenging the United Sates Preventive Services Task Force RecommendationBartolome Celli
Chest|January 21, 2006
COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: time to look beyond the FEV1Bartolome Celli
American Journal of Respiratory and Critical Care Medicine|July 18, 2025
Reply to Bardsley <i>et al.</i>: Current Smoking and Pharmacological Treatment Responses in COPD: Not Clear-CutBartolome Celli
American Journal of Respiratory and Critical Care Medicine|September 29, 2022
Reply to Harber and to Confalonieri <i>et al.</i>Bartolome Celli, Leonardo Fabbri
American Journal of Respiratory and Critical Care Medicine|November 1, 2014
Chronic obstructive pulmonary disease: different risk factors and different natural histories?Jørgen Vestbo, Bartolome Celli
The European Respiratory Journal|December 14, 2023
Reply: Simplifying pharmacotherapy for patients with COPD: a viewpointBartolome Celli, Jørgen Vestbo
Respiration; International Review of Thoracic Diseases|January 17, 2021
Triple Therapy Is Also Effective in Real-World When Used in Chronic Obstructive Pulmonary Disease Patients Who Are Frequent ExacerbatorsMario Cazzola, Bartolome Celli
Archivos De Bronconeumologia|December 4, 2022
Challenges in the Pharmacotherapy of COPD SubtypesFrancesca Polverino, Bartolome Celli
Pageof 14